Condition: Recurrent Osteosarcoma Interventions: Drug: Glembatumumab Vedotin; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Principal Investigator:
Shen, Violet
Research Coordinator:
Kathryn Duvall
(714) 509-8646
Visit clinicaltrials.gov for more information about this trial.
- IRB Number: 160216
- Sponsor: COG
- Protocol Number: AOST1521
- NCT Number: NCT02487979
- Research Type: Recurrent/Refractory Cancer, Solid Tumors
- Phase: II
- Status: Active - Closed to Enrollment
